A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer
(Q44290350)
scientific article
scientific article
Language:
Current Data About
A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer